Australia @ BIO 2014

Australia stamped its presence on the 2014 BIO International Convention in San Diego, giving a strong representation of Australia as a leading biotech location.

A group of Australian organisations spread the word on Australia’s exceptional achievements in medical sciences and technologies. Global companies attending BIO discovered more about Australia’s access to excellent research facilities, world-class scientists, strong collaboration and partnership opportunities, and fast-tracked clinical trials.

Fonterra holds fourth place

New Zealand dairy co-operative Fonterra has once again placed highly in Rabobank’s global ranking of the largest dairy companies in the market. Holding in fourth place in one of the world’s most valuable food sectors, Fonterra has strong expertise in dairy science and technology.

As well as offering traditional dairy products, Fonterra also develops functional bioactive ingredients for specialised nutrition.

By Emma Armitage, Business Analyst, BioPacific Partners

A kiwifruit a day

It’s a billion dokiwifruitllar New Zealand export industry, and everyone knows that fresh fruit is good for you, right? Now Zespri Group are pushing into new commercial frontiers by launching what’s believed to be the world’s first self-substantiating health claim for a fresh fruit. Ten years of clinical data conducted by Zespri show the benefits of the Zespri Green Kiwifruit in maintaining a healthy bowel – bringing them to the brink of joining the international health food market. With research like this going on every day, what’s going to be the next local product to crack a new

For more information see the story here.


Australia, New Zealand, and Singapore have all placed in the Top 10 of the 2014 Scientific American Worldview Scorecard. This key industry index rates the best innovation climates for biotechnology knowledge development.

Australia ranks fourth in the world for its innovation environment, with particular strengths in IP, productivity, and focus on biotech.

New Zealand ranks eighth on the list, noted for its skilled professionals – a key ingredient to biotech success.

Singapore ranks second, commended for its commercially attractive business environment and high number of biotech patents.

BioPacific Partners are proud to source innovation from these outstanding countries.

You can view the full report here.

By Emma Armitage, Business Analyst, BioPacific Partners